U.S. markets close in 3 hours 51 minutes
  • S&P 500

    4,223.80
    +13.56 (+0.32%)
     
  • Dow 30

    33,455.75
    +146.24 (+0.44%)
     
  • Nasdaq

    12,849.31
    -5.49 (-0.04%)
     
  • Russell 2000

    1,981.02
    +11.77 (+0.60%)
     
  • Crude Oil

    93.62
    +1.69 (+1.84%)
     
  • Gold

    1,794.20
    -1.40 (-0.08%)
     
  • Silver

    20.33
    -0.42 (-2.01%)
     
  • EUR/USD

    1.0335
    +0.0033 (+0.3204%)
     
  • 10-Yr Bond

    2.84
    +0.0490 (+1.76%)
     
  • Vix

    20.25
    +0.51 (+2.58%)
     
  • GBP/USD

    1.2221
    +0.0003 (+0.0269%)
     
  • USD/JPY

    132.7230
    -0.1500 (-0.1129%)
     
  • BTC-USD

    24,386.47
    +377.96 (+1.57%)
     
  • CMC Crypto 200

    575.91
    +1.16 (+0.20%)
     
  • FTSE 100

    7,465.91
    -41.20 (-0.55%)
     
  • Nikkei 225

    27,819.33
    -180.67 (-0.65%)
     

Evofem's stock is still up after Friday's Supreme Court decision

·1 min read
Evofem's stock is still up after Friday's Supreme Court decision
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Evofem Biosciences Inc. soared 164.6% in trading on Monday in a rally that began Friday when the Supreme Court decision striking down Roe v. Wade was announced. Evofem makes a birth-control product with a four-year shelf life called Phexxi, a non-hormonal gel that controls pH levels, which reduces the mobility of sperm. The gel is inserted prior to sex. Some experts have speculated that states could place restrictions on some forms of birth control following the decision. Evofem's stoc